Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;38(5):474-485.
doi: 10.2337/cd20-0050.

Automated Insulin Delivery: Easy Enough to Use in Primary Care?

Michael Heile  1 , Betty Hollstegge  1 , Laura Broxterman  1 , Albert Cai  2 , Kelly Close  2
Affiliations

Automated Insulin Delivery: Easy Enough to Use in Primary Care?

Michael Heile et al. Clin Diabetes. 2020 Dec.

Abstract

There are three automated insulin delivery devices on the U.S. market, two of which are currently approved by the U.S. Food and Drug Administration. These systems have already made a significant impact for the people who use them in improving diabetes outcomes, including glycemic control and hypoglycemia prevention. This article aims to help primary care and endocrinology providers better understand the components, differences, limitations, and potential fit of these systems into clinical practice.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
AID survey. Groups polled included three Facebook groups: Your Endo Doctors (2,331 members nationally), Diabetes Technology Clinicians (474 members nationally), and Tristate Endocrinology (24 members from Cincinnati, OH), as well as the large Diabetes Technology Community of Interest Group of the Association of Diabetes Care & Education Specialists and a small international group of endocrinologists contacted individually via e-mail message.
See this image and copyright information in PMC

References

    1. Diabetes Control and Complications Trial Research Group; Nathan DM, Genuth S, Lachin J, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986 - PubMed
    1. UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853 - PubMed
    1. Gubitosi-Klug RA, Braffett BH, White NH, et al.; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group . Risk of severe hypoglycemia in type 1 diabetes over 30 years of follow-up in the DCCT/EDIC study. Diabetes Care 2017;40:1010–1016 - PMC - PubMed
    1. American Diabetes Association 6. Glycemic targets: Standards of Medical Care in Diabetes—2019. Diabetes Care 2019;42(Suppl. 1):S61–S70 - PubMed
    1. Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D Exchange in 2016–2018. Diabetes Technol Ther 2019;21:66–72 - PMC - PubMed